Clinical malaria incidence
Showing 1 - 25 of >10,000
Malaria Trial in Kisumu (Fourstar® granule, 90 day and 180 day briquettes Bti/Bs)
Completed
- Malaria
- Fourstar® granule, 90 day and 180 day briquettes Bti/Bs
-
Kisumu, KenyaKenya Medical Research Institute
Mar 24, 2021
Malaria Trial in Kampala (long lasting insecticidal nets with chlorfenapyr-pyrethroid (PermaNet Dual), long lasting insecticidal
Not yet recruiting
- Malaria
- long lasting insecticidal nets with chlorfenapyr-pyrethroid (PermaNet Dual)
- +2 more
-
Kampala, UgandaInfectious Diseases Research Collaboration
Jul 18, 2023
Malaria, Chemoprophylaxis, Underfive Children Trial in Dar es Salaam (Dihydroartemisinin-piperaquine)
Completed
- Malaria
- +2 more
-
Dar es Salaam, TanzaniaMuhimbili University of Health and Allied Ssciences
May 15, 2023
s, Causes, and Outcomes of Febrile Illness in Rural South and
Recruiting
- Febrile Illness
-
Dhaka, Bangladesh
- +6 more
Jun 6, 2022
Diseases Specified as Adverse Events of Special Interest, of
Active, not recruiting
- Malaria
- Malaria Vaccines
- Blood collection
-
Ouagadougou, Burkina Faso
- +4 more
Oct 18, 2021
Malaria, Vivax, Malaria Trial in Lima (Focal Mass Drug Administration (fMDA))
Not yet recruiting
- Malaria, Vivax
- Malaria
- Focal Mass Drug Administration (fMDA)
-
Lima, PeruUniversidad Peruana de Cayetano Heredia
Jan 18, 2023
Malaria,Falciparum, Anemia in Children Trial in Blantyre (Dihydroartemisinin-Piperaquine, Chloroquine, Sulfadoxine
Completed
- Malaria,Falciparum
- Anemia in Children
- Dihydroartemisinin-Piperaquine
- +2 more
-
Blantyre, MalawiKamuzu University of Health Sciences
Aug 4, 2023
Malaria Trial (BNT165e, Placebo)
Not yet recruiting
- Malaria
- BNT165e
- Placebo
- (no location specified)
Sep 29, 2023
Malaria Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Pvs230D1-EPA/Matrix-M)
Not yet recruiting
- Malaria
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 28, 2023
Malaria Trial in Ouagadougou (Sulphadoxine-Pyrimethamine/Amodiaquine, Dihydroartemisinin/Piperaquine (DP) plus Ivermectin (IVM))
Not yet recruiting
- Malaria
- Sulphadoxine-Pyrimethamine/Amodiaquine
- Dihydroartemisinin/Piperaquine (DP) plus Ivermectin (IVM)
-
Ouagadougou, Burkina FasoMalaria Consortium
Jul 7, 2023
Plasmodium Falciparum Malaria Trial in Mae Sot (Ultrasensitive Rapid Diagnostic Test (URDT), Antimalarials)
Completed
- Plasmodium Falciparum Malaria
- Ultrasensitive Rapid Diagnostic Test (URDT)
- Antimalarials
-
Mae Sot, Tak, ThailandShoklo Malaria Research Unit
Feb 14, 2022
Malaria, Malaria,Falciparum, Parasitic Disease Trial in Oxford (RH5.1 and/or RH5.2-VLP with Matrix-M)
Not yet recruiting
- Malaria
- +4 more
- RH5.1 and/or RH5.2-VLP with Matrix-M
-
Oxford, Oxfordshire, United KingdomCentre for Clinical Vaccinology & Tropical Medicine (CCVTM)
Jul 27, 2023
Malaria Trial in Lambaréné (Vaccine AnAPN1)
Not yet recruiting
- Malaria
- Vaccine AnAPN1
-
Lambaréné, Moyen- Ogooué, GabonCentre de Recherches Médicales de Lammbaréné
Jun 21, 2023
Severe Malaria, Thrombocytopenia Trial in Baltimore, Ndola (Whole blood transfusion)
Not yet recruiting
- Severe Malaria
- Thrombocytopenia
- Whole blood transfusion
-
Baltimore, Maryland
- +1 more
Jan 25, 2023
Efficacy, Malaria, Chloroquine Trial in Arba Minch (Chloroquine, Primaquine)
Completed
- Efficacy
- +3 more
-
Arba Minch, South Ethiopia, EthiopiaShecha Health Center
Sep 19, 2023
l Antimalarial Drugs, Malaria Vaccines, and Controlled Human
Recruiting
- Malaria
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Severe Malaria, Uncomplicated Malaria, Asyptomatic Plasmodium Infection Trial
Not yet recruiting
- Severe Malaria
- +2 more
- (no location specified)
Oct 6, 2023
Malaria, Malaria,Falciparum, Protozoan Infections Trial in Sheffield (Matrix M with RH5.1)
Recruiting
- Malaria
- +5 more
- Matrix M with RH5.1
-
Sheffield, United KingdomSheffield Teaching Hospitals, Royal Hallamshire Hospital
Nov 14, 2023
Host and Parasite Factors That Influence Susceptibility to
Recruiting
- Malaria
-
Bamako, Mali
- +1 more
Jan 18, 2023
Uncomplicated Plasmodium Falciparum Malaria Trial in Bagamoyo (Artemether-lumefantrine and Amodiaquine Drug Combination,
Not yet recruiting
- Uncomplicated Plasmodium Falciparum Malaria
- Artemether-lumefantrine and Amodiaquine Drug Combination
- +2 more
-
Bagamoyo, Dar esSalaam, Tanzania
- +1 more
Feb 28, 2023
Impact of Malaria on Pregnant Women in Ouelessebougou, Mali
Completed
- Malaria
-
Bamako, MaliOuelessebougou Clinical Research Center (Malaria Research and Tr
Jan 19, 2023
Plasmodium Falciparum Malaria Trial in Burkina Faso, Congo, The Democratic Republic of the, Mali (artemether:lumefantrine (2.5
Recruiting
- Plasmodium Falciparum Malaria
- artemether:lumefantrine (2.5 mg:30 mg)
-
Nanoro, Burkina Faso
- +5 more
Nov 28, 2022
Infections, Vector Borne Diseases, Systemic Inflammatory Response Syndrome Trial in Brisbane (MMV367, P. falciparum IBSM
Recruiting
- Infections
- +11 more
- MMV367
- P. falciparum IBSM infection
-
Brisbane, Queensland, Australia
- +1 more
Jul 30, 2023
Malaria Trial in Porto Velho (NxTek™ Malaria P.f plus Rapid Diagnostic Test (RDT) and NxTek™ Malaria P.f/P.v RDT)
Recruiting
- Malaria
- NxTek™ Malaria P.f plus Rapid Diagnostic Test (RDT) and NxTek™ Malaria P.f/P.v RDT
-
Porto Velho, Rondônia, BrazilCentro de Pesquisa em Medicina Tropical de Rondônia (CEPEM)
Sep 23, 2022
Malaria in Pregnancy Trial in Kinshasa (Sulfadoxine pyrimethamine, Pyramax)
Active, not recruiting
- Malaria in Pregnancy
- Sulfadoxine pyrimethamine
- Pyramax
-
Kinshasa, Congo, The Democratic Republic of theMaternité Esengo
Jul 7, 2022